LEO 27847 clinical trials
Also written LEO 27847.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses LEO 27847 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- LEO 27847
- 3
Studies by the year they started
4 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses LEO 27847 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847CompletedPhase 1LEO PharmaNCT01141179Written as LEO 27847How we know
- LEO 27847 - A Study in Healthy Male SubjectsCompletedPhase 1LEO PharmaNCT01007383Written as LEO 27847How we know
- LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy SubjectsCompletedPhase 1LEO PharmaNCT01143298Written as LEO 27847 oral solutionHow we know
- LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism PatientsCompletedPhase 1LEO PharmaNCT01167309Written as LEO 27847How we know